Explore 3 Stock Ideas & Industry Insights Download Free Report

Nanalysis Scientific Corp

Technology CA NSCI

0.13CAD
0.00(0%)

Last update at 2026-06-04T13:30:00Z

Day Range

0.130.13
LowHigh

52 Week Range

0.110.34
LowHigh

Fundamentals

  • Previous Close 0.13
  • Market Cap20.51M
  • Volume878
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.11300M
  • Revenue TTM40.13M
  • Revenue Per Share TTM0.35
  • Gross Profit TTM 9.96M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -5.63900M -13.63500M -16.79500M -10.39900M -1.77200M
Minority interest - - - - -
Net income -5.65800M -13.61300M -16.78400M -9.91500M -1.77200M
Selling general administrative 10.11M 11.29M 12.39M 15.02M 8.28M
Selling and marketing expenses - - - - -
Gross profit 9.96M 12.75M 3.97M 11.14M 10.24M
Reconciled depreciation 3.43M 4.63M 4.67M 4.65M 2.57M
Ebit - - - - -1.19100M
Ebitda - - - -5.26100M 1.38M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -3.76600M -3.44500M -13.46600M -9.91000M -1.19100M
Other operating expenses - - - - -
Interest expense 1.37M 1.34M 0.28M - 0.00000M
Tax provision 0.02M -0.02200M -0.01100M -0.48400M 0.00000M
Interest income - - - - 0.00200M
Net interest income -1.36700M -1.34500M -0.28400M -0.07600M 0.00200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 40.13M 45.49M 28.47M 24.82M 16.04M
Total operating expenses 43.90M 48.94M 41.93M 34.73M 17.23M
Cost of revenue 30.17M 32.75M 24.50M 13.68M 5.80M
Total other income expense net -0.50600M -8.84500M -3.04500M -0.41300M -0.58300M
Discontinued operations - - - - -
Net income from continuing ops -5.65800M -13.61300M -16.78400M -9.91500M -1.77200M
Net income applicable to common shares - - - - -1.77200M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 38.41M 42.37M 53.82M 69.90M 37.79M
Intangible assets 12.39M 13.05M 15.95M 26.63M 14.11M
Earning assets - - - - -
Other current assets 1.43M 1.43M 1.60M 2.06M -
Total liab 24.99M 26.82M 30.34M 22.33M 13.83M
Total stockholder equity 13.42M 15.55M 23.48M 35.13M 23.96M
Deferred long term liab - - - - 12.48M
Other current liab - 0.30M 0.43M 0.81M 2.01M
Common stock - - - - 31.30M
Capital stock 60.20M 57.56M 53.20M 49.02M 31.30M
Retained earnings -54.26000M -48.60200M -34.98900M -18.79300M -9.69200M
Other liab - - - - 1.40M
Good will 5.70M 5.70M 5.70M 13.08M 0.39M
Other assets - - - - 12.48M
Cash 0.55M 1.38M 0.76M 3.52M 10.40M
Cash and equivalents - - - - -
Total current liabilities 17.20M 14.38M 14.60M 13.51M 8.65M
Current deferred revenue - - - - -
Net debt 15.45M 14.78M 18.29M 3.92M -
Short term debt - - - - -
Short long term debt 9.79M 6.01M 6.49M 3.65M 1.94M
Short long term debt total - - - - -
Other stockholder equity - - - - 0.71M
Property plant equipment - - - - 2.54M
Total current assets 16.73M 18.26M 17.91M 21.95M 20.76M
Long term investments - 0.00000M 5.73M - -
Net tangible assets - - - - 21.95M
Short term investments - - - - -
Net receivables 7.39M 9.92M 8.33M 6.08M 6.10M
Long term debt 6.20M 10.14M 12.56M 3.79M 2.75M
Inventory 3.65M 4.39M 5.79M 7.39M 3.68M
Accounts payable 5.20M 5.83M 5.08M 5.76M 4.44M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 1.30M 2.13M 3.11M 0.94M -
Deferred long term asset charges - - - - -
Non current assets total 21.68M 24.11M 35.91M 47.95M 17.03M
Capital lease obligations 1.59M 2.20M 2.92M 3.31M 1.30M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -1.69000M 0.00000M -11.73100M -3.34700M
Change to liabilities - - - - 0.00000M
Total cashflows from investing activities - - - - -3.34700M
Net borrowings -1.40500M -4.16700M 11.57M - 1.17M
Total cash from financing activities 0.11M -0.95600M 14.48M 13.21M 11.79M
Change to operating activities - - - - -2.56300M
Net income -5.65800M -13.61300M -16.78400M -9.91500M -1.77200M
Change in cash 1.78M 0.62M -2.76600M -6.88000M 7.25M
Begin period cash flow 1.38M 0.76M 3.52M 10.40M 3.16M
End period cash flow 3.16M 1.38M 0.76M 3.52M 10.40M
Total cash from operating activities 3.45M 3.26M -11.19200M -8.35500M -1.19900M
Issuance of capital stock - - - - -
Depreciation 3.43M 4.63M 4.67M 4.65M 0.86M
Other cashflows from investing activities - - - - -
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M -
Change to inventory 0.74M 1.42M 0.82M - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - 0.00200M
Change to netincome - - - - 0.57M
Capital expenditures 1.88M 1.86M 4.59M 7.20M 0.59M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 3.73M 1.26M -2.92400M -4.87700M -2.56300M
Stock based compensation 0.40M 1.03M 1.05M 1.56M 0.59M
Other non cash items 1.58M 1.62M -0.51100M 0.15M -0.02200M
Free cash flow 1.57M 1.41M -15.78400M -15.55600M -4.20300M

Peer Comparison

Sector: Technology Industry: Scientific & Technical Instruments

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NSCI
Nanalysis Scientific Corp
- -% 0.13 - 21.74 0.51 1.33 0.87 -31.0169
PNG
Kraken Robotics Inc
0.38 4.89% 8.15 817.00 125.00 24.55 11.20 25.43 163.15
PALS
Paragon Advanced Labs Inc.
-0.05 1.97% 2.49 - - 16.83 -
EDY
Eddy Smart Home Solutions Ltd
- -% 1.50 - - 2.32 0.79 2.44 -2.1406
JTC
JEMTEC Inc
- -% 1.10 16.86 - 1.73 1.25 0.44 2.33

Reports Covered

Stock Research & News

Profile

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60-NMR platform; 100-NMR platform; 60-TEACH Platform; QUAD NMR Console; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, an user interface for data acquisition and processing of benchtop NMR product; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security service, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. The company is headquartered in Calgary, Canada.

Nanalysis Scientific Corp

Bay 1, 4600 5th Street NE, Calgary, AB, Canada, T2E 7C3

Key Executives

Name Title Year Born
Mr. Martin Andrew Burian CPA, CA, CPA Corp. Sec. & Independent Chairman 1964
Mr. Sean Krakiwsky M.Sc. Founder, CEO, Pres & Director 1970
Mr. Julien Muller Chief Technology Officer NA
Mr. Randall McRae C.A., CPA Corp. Controller & Interim CFO NA
Dr. Heather Phillips Director of Operations NA
Mr. Matthew Selinger Investor Relations Mang. NA
Dr. Matt Zamora Sales Mang. NA
Dr. Susanne Riegel Director of Marketing & Product Mang. NA
Dr. Greg McFeetors Head of Manufacturing NA
Mr. Sean Krakiwsky M.Sc. Founder, CEO, President & Director 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.